3187 results for «902»
3187 results
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Choices, choices: a global perspective on multiple modalities for calcium modification
21 May 2025 – From EuroPCR 2025
Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
TAVI for aortic regurgitation: off-label use
21 May 2025 – From EuroPCR 2025
Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...
How complex left main intervention can be?
21 May 2025 – From EuroPCR 2025
Stay updated on the complexities of left main coronary artery interventions with this comprehensive session. Delve into the latest guidelines and trial data for 2025, understand the meticulous preparation and advanced techniques involved, and examine potential adverse effects and complications through real-world complex case scenarios.
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
Devices combination for calcified lesion
20 May 2025 – From EuroPCR 2025
Discover effective device combinations and strategies for managing heavily calcified coronary lesions. This session covers lesion planning using coronary orbit mapping, OCT-guided calcium node identification, rotatripsy techniques, and approaches to complex ostial right coronary artery occlusions, providing practical solutions to challenging calcium riddles.
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
TMVR in challenging scenarios
20 May 2025 – From EuroPCR 2025
Navigate the challenges of transcatheter mitral valve replacement (TMVR) in complex clinical scenarios. This session explores treatment options when clipping is not feasible in a patient with heart failure and severe MR, management of multivalvular disease, advanced septal crossing techniques, and strategies for non-surgical candidates ineligible...
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
Intracoronary imaging real world clinical cases
20 May 2025 – From EuroPCR 2025
Enhance your understanding of intracoronary imaging through real-world clinical cases demonstrating its critical role in complex coronary disease management. This session features cases involving physiological assessment, imaging-guided stent placement, and treatment planning for aneurysms and occlusions, highlighting the value of intravascular imaging in optimizing PCI outcomes.
Transcatheter management of structural defects
20 May 2025 – From EuroPCR 2025
Explore the transcatheter management of structural cardiac defects with challenging clinical scenarios including ventricular septal ruptures and post-TAVI complications. This session emphasizes multidisciplinary approaches and strategic planning to avert catastrophic outcomes and optimize patient care.
The Landmark RCT - One-year results
21 May 2025 – From EuroPCR 2025
This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...
Techniques for the treatment of left main lesions
20 May 2025 – From EuroPCR 2025
Discover contemporary techniques for treating left main coronary artery lesions with a focus on ultra low-contrast PCI, management of calcified Medina 0-0-1 lesions, and troubleshooting intravascular lithotripsy. This session provides practical insights into complex lesion treatment to enhance safety and efficacy.
The new global era of patient care with CathWorks FFRangio
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...
The role of large-bore thrombectomy in my approach to pulmonary embolism management
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of the use of large-bore thrombectomy in the management of pulmonary embolism. It highlights key clinical considerations for intervention, including the potential to reduce fatal events, prevent long-term complications, and optimize cost-effectiveness in eligible patients. A real-life case involving a 65-year-old patient...
Invasive treatment of refractory angina
20 May 2025 – From EuroPCR 2025
Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
